Understanding the Neurovascular Unit and Barrier Integrity

BBB disruption mechanisms serve as a primary catalyst for various neurological disorders. Scientists now understand how brain-infiltrating T cell responses engage the neurovascular unit (NVU). This engagement often leads to neuroinflammation and significant vascular leakage. Furthermore, the role of antigen presentation is crucial in this process. Consequently, discrete MHC class I and class II molecules on NVU cells govern how T cells enter and remain in the brain. Moreover, these interactions determine the extent of barrier disruption. Thus, clinicians must consider these pathways when managing patients with conditions like multiple sclerosis or Parkinson's.

Clinical Significance of BBB Disruption Mechanisms and HLA Genes

In addition, specific HLA genes are linked to these inflammatory processes. Therefore, genetic profiling may offer insights into disease susceptibility. Finally, understanding these mechanisms allows for more targeted therapeutic interventions. This review highlights how the immune system contributes to neuropathology across diverse diseases. Researchers are now focusing on the specific cellular components of the NVU that regulate these responses. This context is vital for understanding vascular leakage in diseases as diverse as cerebral malaria and COVID-19.

Frequently Asked Questions

How do MHC molecules affect the blood-brain barrier?

MHC class I and II molecules on neurovascular unit cells regulate T cell entry and retention, which directly impacts barrier integrity and leads to neuroinflammation.

What neurological diseases are associated with BBB disruption?

Numerous diseases are linked to barrier disruption, including multiple sclerosis, Parkinson's disease, schizophrenia, cerebral malaria, and COVID-19.

Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Maynes MA et al. The impact of antigen presentation on BBB disruption and neuroinflammation. Physiology (Bethesda). 2026 Mar 31. doi: 10.1152/physiol.00041.2025. PMID: 41915408.


2. Engelhardt B, Liebner S. Novel insights into the development and maintenance of the blood-brain barrier. Cell Tissue Res. 2014;355(3):687-99.


3. Zenaro E, et al. Neutrophils promote Alzheimer\'s disease-like pathology and cognitive decline via LFA-1 integrin. Nat Med. 2015;21(8):880-6.